CyberKnife® Always Precise
The CyberKnife® system has been widely used around the world for the treatment of brain cancer and has been proven as a safe and effective treatment for a range of malignant and benign brain conditions.
It is predicted that in Australia, brain cancer will become the 13th most common cause of death in 2018; with approximately 1,935 new brain cancer cases diagnosed annually (Cancer Australia).
The treatment options for brain cancer are largely determined by the type, size and location of the tumour. Current treatments include chemotherapy, surgery or radiotherapy to remove or destroy cancer cells.
Primary and secondary malignant brain lesions.
Benign brain lesions such as AVM (Arteriovenous Malformation), acoustic neuroma, trigeminal neuralgia.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Patient eligibility for CyberKnife® is determined following a thorough consultation with one of our highly experienced Radiation Oncologists.
Our 5D Clinic specialists work closely with your existing medical team to determine whether CyberKnife® treatment is right for you.
CyberKnife® uses a proprietary 6D skull tracking algorithm and frequent x-ray imaging to ensure the exact location of the target is well defined. By taking x-ray images throughout a patient treatment, the CyberKnife system is constantly correcting for any patient movement, with sub-millimetre accuracy.
The non-invasive nature of CyberKnife® treatment delivery makes it an attractive treatment option for many. Unlike GammaKnife and older Radiosurgery techniques which require a rigid immobilisation frame be physically attached to a patient’s skull, CyberKnife® utilises a non-invasive thermoplastic mask for stability of the head and improved comfort for the patient.
Brain treatments with the CyberKnife® are typically delivered over 1 – 3 treatment sessions, with the ability to treat single or multiple brain lesions in one treatment session. Most patients experience minimal side effects and can return to their normal activities immediately following treatment.